Important Information This product is a food supplement and should not be used as a substitute for a varied, balanced diet or healthy lifestyle
The drugs, approved for conditions including diabetes and obesity, help patients feel fuller faster
While both can cause abdominal discomfort, typical semaglutide-related symptoms include diffuse abdominal cramping, nausea, and changes in bowel habits that generally improve over time and are not localized to the right upper quadrant
Be cautious about marketing claims Consumers considering GLP-1 medications for weight loss should keep a few things in mind: Microdosing is not an FDA-approved dosing strategy There are no large clinical trials demonstrating the effectiveness of microdosing for weight loss Microdosing has several risks, particularly when it involves click counting
Therefore, more recent research has shifted the focus to screening a drug that targets the lipotoxicity of individuals with fewer side effects to prevent and treat KOA [10, 11]